Palmitate activates mTOR/p70S6K through AMPK inhibition and hypophosphorylation of raptor in skeletal muscle cells: Reversal by oleate is similar to metformin

Biochimie
Bumsup Kwon, Henry W Querfurth

Abstract

Excessive saturated free fatty acids (SFFAs; e.g. palmitate) in blood are a pathogenic factor in diabetes, obesity, cardiovascular disease and liver failure. In contrast, monounsaturated free fatty acids (e.g. oleate) prevent the toxic effect of SFFAs in various types of cells. The mechanism is poorly understood and involvement of the mTOR complex is untested. In the present study, we demonstrate that oleate preconditioning, as well as coincubation, completely prevented palmitate-induced markers of inflammatory signaling, insulin resistance and cytotoxicity in C2C12 myotubes. We then examined the effect of palmitate and/or oleate on the mammalian target of rapamycin (mTOR) signal path and whether their link is mediated by AMP-activated protein kinase (AMPK). Palmitate decreased the phosphorylation of raptor and 4E-BP1 while increasing the phosphorylation of p70S6K. Palmitate also inhibited phosphorylation of AMPK, but did not change the phosphorylated levels of mTOR or rictor. Oleate completely prevented the palmitate-induced dysregulation of mTOR components and restored pAMPK whereas alone it produced no signaling changes. To understand this more, we show activation of AMPK by metformin also prevented palmitate-induced changes...Continue Reading

References

Jun 11, 1999·Genes & Development·A C GingrasN Sonenberg
Oct 17, 2001·The Journal of Clinical Investigation·G ZhouD E Moller
Mar 27, 2002·The Journal of Biological Chemistry·Masao SaitohGeorge Thomas
Aug 7, 2004·Developmental Cell·Ryan C ScottThomas P Neufeld
Dec 30, 2004·Nature Genetics·Ken InokiKun-Liang Guan
Aug 30, 2005·Biochemical and Biophysical Research Communications·Thomas A MillerDouglas B Sawyer
Feb 1, 2006·Progress in Lipid Research·Scott A Summers
Dec 6, 2006·Essays in Biochemistry·Keith N FraynHannele Yki-Järvinen
Jan 27, 2007·The Journal of Biological Chemistry·Yong WuMing-Hui Zou
Aug 19, 2007·Biochemical and Biophysical Research Communications·Sylvie Mordier, Patrick B Iynedjian
Feb 19, 2008·The Journal of Biological Chemistry·Teresa CollManuel Vázquez-Carrera
Apr 29, 2008·Molecular Cell·Dana M GwinnReuben J Shaw
May 30, 2008·Frontiers in Bioscience : a Journal and Virtual Library·Zilin SunYuefei Liu
Jun 14, 2008·Diabetes/metabolism Research and Reviews·Qiu Gen ZhouXun Zhang
Aug 30, 2008·Current Biology : CB·Audrey CarrièrePhilippe P Roux
Oct 29, 2008·Proceedings of the National Academy of Sciences of the United States of America·Andrew Y ChooJohn Blenis
Jan 1, 2009·American Journal of Physiology. Endocrinology and Metabolism·Kelly A PoseyKevin D Niswender
Jan 20, 2009·The Journal of Biological Chemistry·Carson C ThoreenNathanael S Gray
Feb 10, 2009·Current Opinion in Clinical Nutrition and Metabolic Care·Jeanne Garbarino, Stephen L Sturley
Feb 13, 2009·PLoS Biology·Morris E FeldmanKevan M Shokat
Apr 15, 2009·Gerontology·Maximilian Zeyda, Thomas M Stulnig
Jul 9, 2009·Physiological Reviews·Gregory R Steinberg, Bruce E Kemp
Jul 23, 2009·The British Journal of Nutrition·Dan GaoClifford J Bailey
Sep 18, 2009·The Journal of Biological Chemistry·Yasushi NoguchiGregory Stephanopoulos
Jun 5, 2010·Critical Reviews in Biochemistry and Molecular Biology·Benoit ViolletFabrizio Andreelli
Sep 30, 2010·American Journal of Physiology. Endocrinology and Metabolism·Larysa YuzefovychLyudmila Rachek
Oct 13, 2010·Biochemical and Biophysical Research Communications·Mariko SoumuraTakashi Uzu
Aug 9, 2011·Cellular Signalling·Craig A GoodmanTroy A Hornberger
Oct 4, 2011·Current Opinion in Cell Biology·Eva Dazert, Michael N Hall
Apr 17, 2012·Cell·Mathieu Laplante, David M Sabatini
Jun 19, 2013·The International Journal of Biochemistry & Cell Biology·Anthony M J SanchezHenri Bernardi
Jul 10, 2013·Diabetologia·Graham RenaKei Sakamoto
Jul 26, 2013·American Journal of Physiology. Renal Physiology·Yang GaoHeddwen L Brooks
Jan 1, 2012·ISRN Obesity·Randall W BrynerStephen E Alway

❮ Previous
Next ❯

Citations

Apr 7, 2016·Autophagy·Vinod K MonyEyleen J O'Rourke
Sep 19, 2019·Journal of Medicinal Food·Changhee KimJae-Kwan Hwang
Jan 8, 2020·American Journal of Physiology. Endocrinology and Metabolism·Kostas TsintzasFrancis B Stephens
Nov 28, 2017·Current Genetic Medicine Reports·Eric S Goetzman
Nov 8, 2018·Nutrients·Filip Vlavcheski, Evangelia Tsiani
May 28, 2019·Journal of Comparative Physiology. B, Biochemical, Systemic, and Environmental Physiology·Martin BenzlerAlexander Tups
Jan 17, 2019·Molecular Cancer Research : MCR·Seher BalabanAndrew J Hoy
Jan 6, 2021·International Journal of Molecular Sciences·Gaetan RavautCatherine Mounier
Apr 16, 2017·Biochimica Et Biophysica Acta. Biomembranes·Peixiang Zhang, Karen Reue
Jan 21, 2021·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Hesham ShamshoumEvangelia Tsiani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms